Home Reference intervals for neonatal thyroid function tests in the first 7 days of life
Article
Licensed
Unlicensed Requires Authentication

Reference intervals for neonatal thyroid function tests in the first 7 days of life

  • Michelle S. Jayasuriya , Kay W. Choy EMAIL logo , Lit K. Chin , James Doery , Alice Stewart , Philip Bergman and Zhong X. Lu
Published/Copyright: July 31, 2018

Abstract

Background:

Prompt intervention can prevent permanent adverse neurological effects caused by neonatal hypothyroidism. Thyroid function changes rapidly in the first few days of life but well-defined age-specific reference intervals (RIs) for thyroid-stimulating hormone (TSH), free thyroxine (FT4) and free tri-iodothyronine (FT3) are not available to aid interpretation. We developed hour-based RIs using data mining.

Methods:

All TSH, FT4 and FT3 results with date and time of collection from neonates aged <7 days during 2005–2015 were extracted from the Monash Pathology database. Neonates with more than one episode of testing or with known primary hypothyroidism, identified by treating physicians or from medical records, were excluded from the analysis. The date and time of birth were obtained from the medical records.

Results:

Of the 728 neonates qualifying for the study, 569 had time of birth available. All 569 had TSH, 415 had FT4 and 146 had FT3 results. For age ≤24 h, 25–48 h, 49–72 h, 73–96 h, 97–120 h, 121–144 h and 145–168 h of life, the TSH RIs (2.5th–97.5th) (mIU/L) were 4.1–40.2, 3.2–29.6, 2.6–17.3, 2.2–14.7, 1.8–14.2, 1.4–12.7 and 1.0–8.3, respectively; the FT4 RIs (mean ± 2 standard deviation [SD]) (pmol/L) were 15.3–43.6, 14.7–53.2, 16.5–45.5, 17.8–39.4, 15.3–32.1, 14.5–32.6 and 13.9–30.9, respectively; the FT3 RIs (mean±2 SD) (pmol/L) were 5.0–9.4, 4.1–9.1, 2.8–7.8, 2.9–7.8, 3.5–7.2, 3.4–8.0 and 3.8–7.9, respectively.

Conclusions:

TSH and FT4 were substantially high in the first 24 h after birth followed by a rapid decline over the subsequent 168 h. Use of hour-based RIs in newborns allows for more accurate identification of neonates who are at risk of hypothyroidism.


Corresponding author: Dr. Kay W. Choy, Monash Pathology, Monash Medical Centre, 246 Clayton Road, Clayton, Victoria 3168, Australia, Phone: +(61) 3 9594 4525

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organisation(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Gruters A, Birbermann H, Krude H. Neonatal thyroid disorders. Horm Res 2003;59:S1:24–9.10.1159/000067841Search in Google Scholar PubMed

2. Rovet JF, Ehrlich R. Psychoeducational outcome in children with early-treated congenital hypothyroidism. Pediatrics 2000;105:515–22.10.1542/peds.105.3.515Search in Google Scholar PubMed

3. LaFranchi S. Congenital hypothyroidism: etiologies, diagnosis, and management. Thyroid 1999;9:735–40.10.1089/thy.1999.9.735Search in Google Scholar PubMed

4. Fisher DA, Grueters A. Disorders of the thyroid in the newborn and infant. In: Sperling MA, editor. Pediatric endocrinology. Philadelphia, PA: Saunders, 2008:198–226.10.1016/B978-141604090-3.50011-9Search in Google Scholar

5. Loh TP, Sethi SK, Metz MP. Paediatric reference interval and biological variation trends of thyrotropin (TSH) and free thyroxine (T4) in an Asian population. J Clin Pathol 2015;68:642–7.10.1136/jclinpath-2015-202916Search in Google Scholar PubMed

6. Chaler EA, Fiorenzano R, Chilelli C, Llinares V, Areny G, et al. Age-specific thyroid hormone and thyrotropin reference intervals for a pediatric and adolescent population. Clin Chem Lab Med 2012;50:885–90.10.1515/cclm-2011-0495Search in Google Scholar PubMed

7. Kahapola-Arachchige KM, Hadlow N, Wardrop R, Lim EM, Walsh JP. Age-specific TSH reference ranges have minimal impact on the diagnosis of thyroid dysfunction. Clin Endocrinol (Oxf) 2012;77:773–9.10.1111/j.1365-2265.2012.04463.xSearch in Google Scholar PubMed

8. Iwaku K, Noh JY, Minagawa A, Kosuga Y, Suzuki M, et al. Determination of pediatric reference levels of FT3, FT4 and TSH measured with ECLusys kits. Endocr J 2013;60:799–804.10.1507/endocrj.EJ12-0390Search in Google Scholar

9. Chan MK, Seiden-Long I, Aytekin M, Quinn F, Ravalico T, et al. Canadian Laboratory Initiative on Pediatric Reference Interval Database (CALIPER): pediatric reference intervals for an integrated clinical chemistry and immunoassay analyzer, Abbott ARCHITECT ci8200. Clin Biochem 2009;42:885–91.10.1016/j.clinbiochem.2009.01.014Search in Google Scholar PubMed

10. Henderson MP, Grey V. Establishing and evaluating pediatric thyroid reference intervals on the Roche Modular Analytics E 170 using computational statistics and data-mining techniques. Clin Biochem 2011;44:767–70.10.1016/j.clinbiochem.2011.05.006Search in Google Scholar PubMed

11. Aldrimer M, Ridefelt P, Rödöö P, Niklasson F, Gustafsson J, et al. Reference intervals on the Abbot Architect for serum thyroid hormones, lipids and prolactin in healthy children in a population-based study. Scand J Clin Lab Invest 2012;72: 326–32.10.3109/00365513.2012.667571Search in Google Scholar PubMed

12. Bailey D, Colantonio D, Kyriakopoulou L, Cohen AH, Chan MK, et al. Marked biological variance in endocrine and biochemical markers in childhood: establishment of pediatric reference intervals using healthy community children from the CALIPER cohort. Clin Chem 2013;59:1393–405.10.1373/clinchem.2013.204222Search in Google Scholar PubMed

13. Elmlinger MW, Kuhnel W, Lambrecht HG, Ranke MB. Reference intervals from birth to adulthood for serum thyroxine (T4), triiodothyronine (T3), free T3, free T4, thyroxine binding globulin (TBG) and thyrotropin (TSH). Clin Chem Lab Med 2001;39:973–9.10.1515/CCLM.2001.158Search in Google Scholar PubMed

14. Fideleff G, Suarez MG, Sobrado PG, Celadilla ML, Mardyks M, et al. Confirmation of neonatal screening: reference intervals and evaluation of methodological changes in TSH measurement. J Pediatr Endocrinol Metab 2010;23:759–64.10.1515/jpem.2010.125Search in Google Scholar PubMed

15. Lott JA, Sardovia-Iyer M, Speakman KS, Lee KK. Age-dependent cutoff values in screening newborns for hypothyroidism. Clin Biochem 2004;37:791–7.10.1016/j.clinbiochem.2004.05.019Search in Google Scholar PubMed

16. Kawahara K, Yokoya S. Establishment of reference intervals of thyrotropin and free thyroid hormones during the first week of life. Clin Pediatr Endocrinol 2002;11:1–9.10.1297/cpe.11.1Search in Google Scholar

17. Sheikhbahaei S, Mahdaviani B, Abdollahi A, Nayeri F. Serum thyroid stimulating hormone, total and free T4 during the neonatal period: establishing regional reference intervals. Indian J Endocr Metab 2014;18:39.10.4103/2230-8210.126528Search in Google Scholar PubMed PubMed Central

18. Omuse G, Kassim A, Kiigu F, Hussain SR, Limbe M. Reference intervals for thyroid stimulating hormone and free thyroxine derived from neonates undergoing routine screening for congenital hypothyroidism at a university teaching hospital in Nairobi, Kenya: a cross sectional study. BMC Endocr Disord 2016;16:23.10.1186/s12902-016-0107-9Search in Google Scholar PubMed PubMed Central

19. Omuse G, Kassim A, Kiigu F, Hussain SR, Limbe M. Erratum to: Reference intervals for thyroid stimulating hormone and free thyroxine derived from neonates undergoing routine screening for congenital hypothyroidism at a university teaching hospital in Nairobi, Kenya: a cross sectional study. BMC Endocr Disord 2017;17:21.10.1186/s12902-017-0171-9Search in Google Scholar PubMed PubMed Central

Received: 2018-01-03
Accepted: 2018-07-12
Published Online: 2018-07-31
Published in Print: 2018-10-25

©2018 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Original Articles
  3. The associations between mental health, health-related quality of life and insulin pump therapy among children and adolescents with type 1 diabetes
  4. Achieving target levels for vascular risk parameters in Polish school-age children with type 1 diabetes – a single center study
  5. Adipocyte aquaporin 7 (AQP7) expression in lean children and children with obesity. Possible involvement in molecular mechanisms of childhood obesity
  6. Use of complementary and alternative medicine in patients with inherited metabolic disease
  7. Are breast milk adipokines affected by maternal dietary factors?
  8. Comparison of serum 25-hydroxyvitamin D levels between radioimmunoassay and liquid chromatography-tandem mass spectrometry in infants and postpartum women
  9. Reference intervals for neonatal thyroid function tests in the first 7 days of life
  10. Treatment outcomes in pediatric differentiated thyroid carcinoma
  11. Seasonality of month of birth in children and adolescents with autoimmune thyroiditis: a continuing conundrum
  12. Follow-up in children with non-obese and non-autoimmune subclinical hypothyroidism
  13. Glucose intolerance in children with cystic fibrosis: a developing country’s perspective
  14. Letter to the Editor
  15. A patient with classical galactosemia is graduated with a university degree
  16. Case Reports
  17. Prepubertal gynaecomastia in a boy with Peutz-Jeghers syndrome: managing the aromatase overexpression
  18. Hypogammaglobulinemia and imaging features in a patient with infantile free sialic acid storage disease (ISSD) and a novel mutation in the SLC17A5 gene
  19. Xanthogranuloma of the sellar region accompanied by growth hormone deficiency: case report and literature review
  20. A case of Graves’ disease associated with membranoproliferative glomerulonephritis and leukocytoclastic vasculitis
Downloaded on 24.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2018-0007/html
Scroll to top button